Caprolactam Chemicals Stock Screener | Share Price & Fundamental Analysis
CAPRO
Commodity Chemicals
Screen Caprolactam Chemicals share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹54.00
▲
2.00 (3.85%)
Market Cap
₹25.48 Cr.
P/B Ratio
4.60
EPS (TTM)
₹-1.54
Dividend Yield
-
Debt to Equity
1.41
52W High
₹66.50
52W Low
₹38.25
Operating Margin
26.00%
Profit Margin
-
Revenue (TTM)
₹9.00
EBITDA
₹2.00
Net Income
-
Total Assets
₹14.00
Total Equity
₹5.00
Caprolactam Chemicals Share Price History - Stock Screener Chart
Screen CAPRO historical share price movements with interactive charts. Analyze price trends and patterns.
Caprolactam Chemicals Company Profile - Fundamental Screener
Screen Caprolactam Chemicals company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CAPRO shares.
Sector
Chemicals
Industry
Commodity Chemicals
Sub-Sector
Commodity Chemicals
Segment
E
ISIN
INE470N01010
Caprolactam Chemicals Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen CAPRO balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 14 | 12 | 12 | 10 | 7 | 7 | 7 | 6 | 4 | 4 |
| Current Assets | 4 | 1 | 1 | 1 | 2 | 1 | 1 | 2 | 1 | 1 |
| Fixed Assets | 10 | 10 | 10 | 5 | 6 | 6 | 6 | 4 | 3 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 14 | 12 | 12 | 10 | 7 | 7 | 7 | 6 | 4 | 4 |
| Current Liabilities | 0 | 0 | 3 | 3 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 5 | 6 | 5 | 3 | 4 | 4 | 3 | 2 | 2 | 2 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves & Surplus | 0 | 1 | 1 | -2 | -1 | -1 | -2 | -3 | -3 | -3 |
Screen CAPRO income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 9 | 7 | 7 | 10 | 3 | 6 | 7 | 5 | 4 | 3 | 5 | 3 |
| Expenses | 6 | 5 | 5 | 5 | 3 | 4 | 4 | 3 | 3 | 3 | 4 | 3 |
| EBITDA | 2 | 2 | 2 | 5 | 0 | 2 | 3 | 2 | 1 | 1 | 1 | 0 |
| Operating Profit % | 26.00% | 23.00% | 31.00% | 48.00% | -27.00% | 34.00% | 39.00% | 36.00% | 22.00% | 14.00% | 17.00% | 13.00% |
| Depreciation | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -1 | 0 | 3 | -2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -1 | 0 | 3 | -1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
| EPS | 0.00 | -1.54 | 0.43 | 5.54 | -2.79 | 1.41 | 2.07 | 1.09 | 0.37 | -0.25 | 1.13 | -0.12 |
Caprolactam Chemicals Cash Flow Screener - Liquidity Fundamentals
Screen CAPRO cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | 2 | 1 | 3 | 1 | 2 | 3 | 1 | 1 | 1 |
| Investing Activities | -2 | -2 | -2 | -5 | -1 | -1 | -4 | -1 | -1 | -1 |
| Financing Activities | 2 | 0 | 1 | 1 | -1 | -1 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 1 | 0 | 0 |
Screen CAPRO shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 54.02% | 54.04% | 54.05% | 53.97% | 53.97% | 53.97% | 53.99% | 52.60% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 43.84% | 43.83% | 43.78% | 43.81% | 43.86% | 43.90% | 43.87% | 45.20% |
| Other Holding | 2.14% | 2.13% | 2.16% | 2.22% | 2.17% | 2.13% | 2.14% | 2.19% |
| Shareholder Count | 8,180 | 8,158 | 8,142 | 8,087 | 8,182 | 8,219 | 8,240 | 7,900 |
Caprolactam Chemicals Dividend Screener - Share Yield Analysis
Screen CAPRO dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Caprolactam Chemicals Index Membership - Market Screener Classification
Screen CAPRO by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Caprolactam Chemicals Market Events Screener - Corporate Actions
Screen CAPRO market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 5.04% | ||
| Annual General Meeting | NA | 4.01% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | 9.46% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -0.26% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -1.60% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -3.86% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | -1.49% |
Caprolactam Chemicals Competitors Screener - Peer Comparison
Screen CAPRO competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Tata Chemicals | 19,625 | 48.48 | 15,112 | -3.79% | 354 | 34.41 |
| Deepak Fertilisers & Petrochemicals | 15,624 | 15.38 | 10,355 | 17.69% | 945 | 30.11 |
| Gujarat Narmada Valley Fert & Chem | 7,194 | 11.23 | 8,393 | -0.07% | 586 | 38.86 |
| GHCL | 5,466 | 9.21 | 3,271 | -6.51% | 624 | 42.19 |
| Blue Pearl Agriventures | 5,380 | 9397.00 | 35 | 11666.67% | 1 | 50.76 |
| Tanfac Industries | 4,244 | 44.85 | 560 | 45.35% | 88 | 61.82 |
| Chemplast Sanmar | 4,191 | -17.96 | 4,393 | 9.61% | -110 | 15.65 |
| Gujarat Alkalies & Chemicals | 3,709 | 25292.50 | 4,165 | 6.89% | -65 | 33.51 |
| Grauer & Weil | 3,394 | 22.51 | 1,180 | 7.28% | 157 | 33.97 |
| Fischer Medical Ventures | 2,803 | 141.48 | 112 | 421.86% | 1 | 32.02 |
Caprolactam Chemicals Company Announcements - News Screener
Screen CAPRO latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-01 | Submission Of Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 Form C | View |
| 2025-12-01 | Submission Of Disclosure Under Regulation 7(2) Of SEBI (Prohibition Of Insider Trading) Regulations 2015 Form C | View |
| 2025-12-01 | Disclosures Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | View |
| 2025-11-28 | Disclosures Under Regulations 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | View |
| 2025-11-28 | Disclosures Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | View |
| 2025-11-26 | Disclosures Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | View |
| 2025-11-25 | Disclosures Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | View |
| 2025-11-21 | Disclosures Under Regulation 29 (2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | View |
| 2025-11-20 | Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 | View |
| 2025-11-15 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-14 | Board Meeting Outcome for Submission Of The Unaudited Financial Results For Quarter And Half Year Ended 30Th September 2025 | View |
| 2025-10-24 | Board Meeting Intimation for Unaudited Financial Results For The Half Year Ended 30Th September 2025 | View |
| 2025-10-16 | Non Submission Of Related Party Transaction In XBRL Mode Under Reg.23(9) For The Period Ended 30Th September. 2025 | View |
| 2025-10-03 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-30 | Closure of Trading Window | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-25 | Intimation Of Re Appointment Of Managing Director And Whole Time Director And CFO And Appointment Of Secretarial Auditor - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-26 | Disclosure Under Regulation 29(2) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011. | View |
| 2025-08-20 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |